NCT04370782View on ClinicalTrials.gov

Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
COVID-19
Interventions
DRUG

Hydroxychloroquine

Hydroxychloroquine 400mg twice a day (BID) on day 1, followed by 200mg BID for days 2-5

DRUG

Azithromycin

Azithromycin 500mg on day 1, followed by 250mg once daily for days 2-5

DRUG

Zinc Sulfate

Zinc sulfate 220mg once daily for 5 days

DRUG

Doxycycline

Doxycycline 200 mg once daily for 5 days

Trial Locations (1)

11576

St Francis Hospital, Roslyn

All Listed Sponsors
lead

St. Francis Hospital, New York

OTHER

NCT04370782 - Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting | Biotech Hunter | Biotech Hunter